arginyl-glycyl-aspartic acid has been researched along with asbestos, crocidolite in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broaddus, VC; Ernst, JD; Liu, W | 1 |
| Leyva, FJ; Roberts, K | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and asbestos, crocidolite
| Article | Year |
|---|---|
Phagocytosis of crocidolite asbestos induces oxidative stress, DNA damage, and apoptosis in mesothelial cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Asbestos, Crocidolite; Cells, Cultured; Cytochalasin B; DNA Damage; G2 Phase; Mitosis; Oligopeptides; Oxidative Stress; Phagocytosis; Pleura; Rabbits; Respiratory Mucosa; Serum Albumin, Bovine; Vitronectin | 2000 |
Crocidolite induces prostaglandin I(2) release mediated by vitronectin receptor and cyclooxygenase-2 in lung cells.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Asbestos, Crocidolite; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Dose-Response Relationship, Drug; Epithelial Cells; Epoprostenol; Integrin alphaVbeta3; L-Lactate Dehydrogenase; Lung; Mice; Mice, Inbred BALB C; Oligopeptides; Signal Transduction | 2010 |